img

Global Binge Eating Disorder Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Binge Eating Disorder Treatment Market Research Report 2024

According to MRAResearch’s new survey, global Binge Eating Disorder Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Binge Eating Disorder Treatment market research.
Key companies engaged in the Binge Eating Disorder Treatment industry include Chronos Therapeutics, Shire US Inc. (part of Takeda Pharmaceutical Company), Eli Lilly and Company, Sunovion Pharmaceuticals Inc, Promises Behavioral Health, Pyramid Healthcare (Tapestry Eating Disorder Services), Timberline Knolls, Rosewood Centers for Eating Disorders and Walden Behavioral Care, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Binge Eating Disorder Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Binge Eating Disorder Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Binge Eating Disorder Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Chronos Therapeutics
Shire US Inc. (part of Takeda Pharmaceutical Company)
Eli Lilly and Company
Sunovion Pharmaceuticals Inc
Promises Behavioral Health
Pyramid Healthcare (Tapestry Eating Disorder Services)
Timberline Knolls
Rosewood Centers for Eating Disorders
Walden Behavioral Care
Roche
Opiant Pharmaceuticals
Heptares
Novo Nordisk
Omeros Corp
Segment by Type
Medication
Services

Segment by Application


Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Binge Eating Disorder Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Binge Eating Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Medication
1.2.3 Services
1.3 Market by Application
1.3.1 Global Binge Eating Disorder Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Binge Eating Disorder Treatment Market Perspective (2018-2033)
2.2 Binge Eating Disorder Treatment Growth Trends by Region
2.2.1 Global Binge Eating Disorder Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Binge Eating Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Binge Eating Disorder Treatment Forecasted Market Size by Region (2024-2033)
2.3 Binge Eating Disorder Treatment Market Dynamics
2.3.1 Binge Eating Disorder Treatment Industry Trends
2.3.2 Binge Eating Disorder Treatment Market Drivers
2.3.3 Binge Eating Disorder Treatment Market Challenges
2.3.4 Binge Eating Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Binge Eating Disorder Treatment Players by Revenue
3.1.1 Global Top Binge Eating Disorder Treatment Players by Revenue (2018-2023)
3.1.2 Global Binge Eating Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Binge Eating Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Binge Eating Disorder Treatment Revenue
3.4 Global Binge Eating Disorder Treatment Market Concentration Ratio
3.4.1 Global Binge Eating Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Binge Eating Disorder Treatment Revenue in 2022
3.5 Binge Eating Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Binge Eating Disorder Treatment Product Solution and Service
3.7 Date of Enter into Binge Eating Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Binge Eating Disorder Treatment Breakdown Data by Type
4.1 Global Binge Eating Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Binge Eating Disorder Treatment Forecasted Market Size by Type (2024-2033)
5 Binge Eating Disorder Treatment Breakdown Data by Application
5.1 Global Binge Eating Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Binge Eating Disorder Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Binge Eating Disorder Treatment Market Size (2018-2033)
6.2 North America Binge Eating Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Binge Eating Disorder Treatment Market Size by Country (2018-2023)
6.4 North America Binge Eating Disorder Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Binge Eating Disorder Treatment Market Size (2018-2033)
7.2 Europe Binge Eating Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Binge Eating Disorder Treatment Market Size by Country (2018-2023)
7.4 Europe Binge Eating Disorder Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Binge Eating Disorder Treatment Market Size (2018-2033)
8.2 Asia-Pacific Binge Eating Disorder Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Binge Eating Disorder Treatment Market Size (2018-2033)
9.2 Latin America Binge Eating Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Binge Eating Disorder Treatment Market Size by Country (2018-2023)
9.4 Latin America Binge Eating Disorder Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Binge Eating Disorder Treatment Market Size (2018-2033)
10.2 Middle East & Africa Binge Eating Disorder Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chronos Therapeutics
11.1.1 Chronos Therapeutics Company Detail
11.1.2 Chronos Therapeutics Business Overview
11.1.3 Chronos Therapeutics Binge Eating Disorder Treatment Introduction
11.1.4 Chronos Therapeutics Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.1.5 Chronos Therapeutics Recent Development
11.2 Shire US Inc. (part of Takeda Pharmaceutical Company)
11.2.1 Shire US Inc. (part of Takeda Pharmaceutical Company) Company Detail
11.2.2 Shire US Inc. (part of Takeda Pharmaceutical Company) Business Overview
11.2.3 Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Introduction
11.2.4 Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.2.5 Shire US Inc. (part of Takeda Pharmaceutical Company) Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Detail
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Binge Eating Disorder Treatment Introduction
11.3.4 Eli Lilly and Company Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.3.5 Eli Lilly and Company Recent Development
11.4 Sunovion Pharmaceuticals Inc
11.4.1 Sunovion Pharmaceuticals Inc Company Detail
11.4.2 Sunovion Pharmaceuticals Inc Business Overview
11.4.3 Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Introduction
11.4.4 Sunovion Pharmaceuticals Inc Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.4.5 Sunovion Pharmaceuticals Inc Recent Development
11.5 Promises Behavioral Health
11.5.1 Promises Behavioral Health Company Detail
11.5.2 Promises Behavioral Health Business Overview
11.5.3 Promises Behavioral Health Binge Eating Disorder Treatment Introduction
11.5.4 Promises Behavioral Health Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.5.5 Promises Behavioral Health Recent Development
11.6 Pyramid Healthcare (Tapestry Eating Disorder Services)
11.6.1 Pyramid Healthcare (Tapestry Eating Disorder Services) Company Detail
11.6.2 Pyramid Healthcare (Tapestry Eating Disorder Services) Business Overview
11.6.3 Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Introduction
11.6.4 Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.6.5 Pyramid Healthcare (Tapestry Eating Disorder Services) Recent Development
11.7 Timberline Knolls
11.7.1 Timberline Knolls Company Detail
11.7.2 Timberline Knolls Business Overview
11.7.3 Timberline Knolls Binge Eating Disorder Treatment Introduction
11.7.4 Timberline Knolls Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.7.5 Timberline Knolls Recent Development
11.8 Rosewood Centers for Eating Disorders
11.8.1 Rosewood Centers for Eating Disorders Company Detail
11.8.2 Rosewood Centers for Eating Disorders Business Overview
11.8.3 Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Introduction
11.8.4 Rosewood Centers for Eating Disorders Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.8.5 Rosewood Centers for Eating Disorders Recent Development
11.9 Walden Behavioral Care
11.9.1 Walden Behavioral Care Company Detail
11.9.2 Walden Behavioral Care Business Overview
11.9.3 Walden Behavioral Care Binge Eating Disorder Treatment Introduction
11.9.4 Walden Behavioral Care Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.9.5 Walden Behavioral Care Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Binge Eating Disorder Treatment Introduction
11.10.4 Roche Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.10.5 Roche Recent Development
11.11 Opiant Pharmaceuticals
11.11.1 Opiant Pharmaceuticals Company Detail
11.11.2 Opiant Pharmaceuticals Business Overview
11.11.3 Opiant Pharmaceuticals Binge Eating Disorder Treatment Introduction
11.11.4 Opiant Pharmaceuticals Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.11.5 Opiant Pharmaceuticals Recent Development
11.12 Heptares
11.12.1 Heptares Company Detail
11.12.2 Heptares Business Overview
11.12.3 Heptares Binge Eating Disorder Treatment Introduction
11.12.4 Heptares Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.12.5 Heptares Recent Development
11.13 Novo Nordisk
11.13.1 Novo Nordisk Company Detail
11.13.2 Novo Nordisk Business Overview
11.13.3 Novo Nordisk Binge Eating Disorder Treatment Introduction
11.13.4 Novo Nordisk Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.13.5 Novo Nordisk Recent Development
11.14 Omeros Corp
11.14.1 Omeros Corp Company Detail
11.14.2 Omeros Corp Business Overview
11.14.3 Omeros Corp Binge Eating Disorder Treatment Introduction
11.14.4 Omeros Corp Revenue in Binge Eating Disorder Treatment Business (2018-2023)
11.14.5 Omeros Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Binge Eating Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Medication
Table 3. Key Players of Services
Table 4. Global Binge Eating Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Binge Eating Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Binge Eating Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Binge Eating Disorder Treatment Market Share by Region (2018-2023)
Table 8. Global Binge Eating Disorder Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Binge Eating Disorder Treatment Market Share by Region (2024-2033)
Table 10. Binge Eating Disorder Treatment Market Trends
Table 11. Binge Eating Disorder Treatment Market Drivers
Table 12. Binge Eating Disorder Treatment Market Challenges
Table 13. Binge Eating Disorder Treatment Market Restraints
Table 14. Global Binge Eating Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Binge Eating Disorder Treatment Market Share by Players (2018-2023)
Table 16. Global Top Binge Eating Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Binge Eating Disorder Treatment as of 2022)
Table 17. Ranking of Global Top Binge Eating Disorder Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Binge Eating Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Binge Eating Disorder Treatment Product Solution and Service
Table 21. Date of Enter into Binge Eating Disorder Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Binge Eating Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Binge Eating Disorder Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Binge Eating Disorder Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Binge Eating Disorder Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Binge Eating Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Binge Eating Disorder Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Binge Eating Disorder Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Binge Eating Disorder Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Binge Eating Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Binge Eating Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Binge Eating Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Binge Eating Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Binge Eating Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Binge Eating Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Binge Eating Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Chronos Therapeutics Company Detail
Table 47. Chronos Therapeutics Business Overview
Table 48. Chronos Therapeutics Binge Eating Disorder Treatment Product
Table 49. Chronos Therapeutics Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 50. Chronos Therapeutics Recent Development
Table 51. Shire US Inc. (part of Takeda Pharmaceutical Company) Company Detail
Table 52. Shire US Inc. (part of Takeda Pharmaceutical Company) Business Overview
Table 53. Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Product
Table 54. Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 55. Shire US Inc. (part of Takeda Pharmaceutical Company) Recent Development
Table 56. Eli Lilly and Company Company Detail
Table 57. Eli Lilly and Company Business Overview
Table 58. Eli Lilly and Company Binge Eating Disorder Treatment Product
Table 59. Eli Lilly and Company Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 60. Eli Lilly and Company Recent Development
Table 61. Sunovion Pharmaceuticals Inc Company Detail
Table 62. Sunovion Pharmaceuticals Inc Business Overview
Table 63. Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Product
Table 64. Sunovion Pharmaceuticals Inc Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 65. Sunovion Pharmaceuticals Inc Recent Development
Table 66. Promises Behavioral Health Company Detail
Table 67. Promises Behavioral Health Business Overview
Table 68. Promises Behavioral Health Binge Eating Disorder Treatment Product
Table 69. Promises Behavioral Health Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 70. Promises Behavioral Health Recent Development
Table 71. Pyramid Healthcare (Tapestry Eating Disorder Services) Company Detail
Table 72. Pyramid Healthcare (Tapestry Eating Disorder Services) Business Overview
Table 73. Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Product
Table 74. Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 75. Pyramid Healthcare (Tapestry Eating Disorder Services) Recent Development
Table 76. Timberline Knolls Company Detail
Table 77. Timberline Knolls Business Overview
Table 78. Timberline Knolls Binge Eating Disorder Treatment Product
Table 79. Timberline Knolls Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 80. Timberline Knolls Recent Development
Table 81. Rosewood Centers for Eating Disorders Company Detail
Table 82. Rosewood Centers for Eating Disorders Business Overview
Table 83. Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Product
Table 84. Rosewood Centers for Eating Disorders Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 85. Rosewood Centers for Eating Disorders Recent Development
Table 86. Walden Behavioral Care Company Detail
Table 87. Walden Behavioral Care Business Overview
Table 88. Walden Behavioral Care Binge Eating Disorder Treatment Product
Table 89. Walden Behavioral Care Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 90. Walden Behavioral Care Recent Development
Table 91. Roche Company Detail
Table 92. Roche Business Overview
Table 93. Roche Binge Eating Disorder Treatment Product
Table 94. Roche Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Opiant Pharmaceuticals Company Detail
Table 97. Opiant Pharmaceuticals Business Overview
Table 98. Opiant Pharmaceuticals Binge Eating Disorder Treatment Product
Table 99. Opiant Pharmaceuticals Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 100. Opiant Pharmaceuticals Recent Development
Table 101. Heptares Company Detail
Table 102. Heptares Business Overview
Table 103. Heptares Binge Eating Disorder Treatment Product
Table 104. Heptares Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 105. Heptares Recent Development
Table 106. Novo Nordisk Company Detail
Table 107. Novo Nordisk Business Overview
Table 108. Novo Nordisk Binge Eating Disorder Treatment Product
Table 109. Novo Nordisk Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 110. Novo Nordisk Recent Development
Table 111. Omeros Corp Company Detail
Table 112. Omeros Corp Business Overview
Table 113. Omeros Corp Binge Eating Disorder Treatment Product
Table 114. Omeros Corp Revenue in Binge Eating Disorder Treatment Business (2018-2023) & (US$ Million)
Table 115. Omeros Corp Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Binge Eating Disorder Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Binge Eating Disorder Treatment Market Share by Type: 2022 VS 2033
Figure 3. Medication Features
Figure 4. Services Features
Figure 5. Global Binge Eating Disorder Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Binge Eating Disorder Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Binge Eating Disorder Treatment Report Years Considered
Figure 10. Global Binge Eating Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Binge Eating Disorder Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Binge Eating Disorder Treatment Market Share by Region: 2022 VS 2033
Figure 13. Global Binge Eating Disorder Treatment Market Share by Players in 2022
Figure 14. Global Top Binge Eating Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Binge Eating Disorder Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Binge Eating Disorder Treatment Revenue in 2022
Figure 16. North America Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Binge Eating Disorder Treatment Market Share by Country (2018-2033)
Figure 18. United States Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Binge Eating Disorder Treatment Market Share by Country (2018-2033)
Figure 22. Germany Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Binge Eating Disorder Treatment Market Share by Region (2018-2033)
Figure 30. China Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Binge Eating Disorder Treatment Market Share by Country (2018-2033)
Figure 38. Mexico Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Binge Eating Disorder Treatment Market Share by Country (2018-2033)
Figure 42. Turkey Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Binge Eating Disorder Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Chronos Therapeutics Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 45. Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 46. Eli Lilly and Company Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 47. Sunovion Pharmaceuticals Inc Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 48. Promises Behavioral Health Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 49. Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 50. Timberline Knolls Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 51. Rosewood Centers for Eating Disorders Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 52. Walden Behavioral Care Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 53. Roche Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 54. Opiant Pharmaceuticals Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 55. Heptares Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 56. Novo Nordisk Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 57. Omeros Corp Revenue Growth Rate in Binge Eating Disorder Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed